These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29168654)

  • 1. Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.
    Havard R; Henry NL
    Future Oncol; 2017 Dec; 13(28):2507-2510. PubMed ID: 29168654
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.
    Ethier JL; Amir E
    Mol Diagn Ther; 2016 Aug; 20(4):307-13. PubMed ID: 27235162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of molecular tools for extended adjuvant endocrine therapy decisions in early breast cancer.
    Ribnikar D; Bedard PL
    Future Oncol; 2017 Dec; 13(30):2733-2736. PubMed ID: 29168649
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry.
    Henry NL; Braun TM; Ali HY; Munir K; Silver SM; Gorski DH; Breslin TM; Griggs JJ
    Cancer; 2017 May; 123(6):948-956. PubMed ID: 27787892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study.
    Kuijer A; Drukker CA; Elias SG; Smorenburg CH; Th Rutgers EJ; Siesling S; van Dalen T
    Int J Cancer; 2016 Aug; 139(4):769-75. PubMed ID: 27062369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer genomics: real-time use.
    Bertucci F; Birnbaum D
    Lancet Oncol; 2007 Dec; 8(12):1045-1047. PubMed ID: 18054870
    [No Abstract]   [Full Text] [Related]  

  • 7. Individualizing therapeutic decision making in early-stage breast cancer.
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):41-2. PubMed ID: 17824559
    [No Abstract]   [Full Text] [Related]  

  • 8. Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.
    El Hage Chehade H; Wazir U; Mokbel K; Kasem A; Mokbel K
    Am J Surg; 2018 Jan; 215(1):171-178. PubMed ID: 28622841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
    Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-generation genomic tests for breast cancer treatment.
    Andre F; Delaloge S
    Lancet Oncol; 2010 Jan; 11(1):6-7. PubMed ID: 20005177
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer.
    Savci-Heijink CD; Halfwerk H; Koster J; Van de Vijver MJ
    BMC Cancer; 2017 Nov; 17(1):755. PubMed ID: 29132326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX
    Curtit E; Mansi L; Maisonnette-Escot Y; Sautière JL; Pivot X
    Eur J Surg Oncol; 2017 May; 43(5):921-930. PubMed ID: 28087099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score.
    Yardley DA; Peacock NW; Shastry M; Burris HA; Bechhold RG; Hendricks CB; Yoshizawa CN; Sing AP; Hainsworth JD
    Breast Cancer Res Treat; 2015 Nov; 154(2):299-308. PubMed ID: 26507191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response.
    Magbanua MJ; Wolf DM; Yau C; Davis SE; Crothers J; Au A; Haqq CM; Livasy C; Rugo HS; ; Esserman L; Park JW; van 't Veer LJ
    Breast Cancer Res; 2015 May; 17(1):73. PubMed ID: 26021444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multigene prognostic tests in breast cancer: past, present, future.
    Győrffy B; Hatzis C; Sanft T; Hofstatter E; Aktas B; Pusztai L
    Breast Cancer Res; 2015 Jan; 17(1):11. PubMed ID: 25848861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study.
    Kuchel A; Robinson T; Comins C; Shere M; Varughese M; Sparrow G; Sahu A; Saunders L; Bahl A; Cawthorn SJ; Braybrooke JP
    Br J Cancer; 2016 Mar; 114(7):731-6. PubMed ID: 26954715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Online accounts of gene expression profiling in early-stage breast cancer: Interpreting genomic testing for chemotherapy decision making.
    Ross E; Swallow J; Kerr A; Cunningham-Burley S
    Health Expect; 2019 Feb; 22(1):74-82. PubMed ID: 30387238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
    Santa-Maria CA; Kruse M; Raska P; Weiss M; Swoboda A; Mutonga MB; Abraham J; Jain S; Nanda R; Montero AJ
    Breast Cancer Res Treat; 2017 Nov; 166(1):179-184. PubMed ID: 28752189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating breast cancer genetics into clinical practice.
    Mukherjee A; Rakha EA
    Womens Health (Lond); 2012 Jan; 8(1):99-112. PubMed ID: 22171779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.